Stage IV Nasopharyngeal Carcinoma AJCC v8
9 clinical trials · Condition
◉ Watch Stage IV Nasopharyngeal Carcinoma AJCC v8
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer (NCT04458909) | National Cancer Institute (NCI) | 2020-12-09 |
| Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer (NCT03010150) | M.D. Anderson Cancer Center | 2016-12-29 |
Track Stage IV Nasopharyngeal Carcinoma AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.